神経治療学
Online ISSN : 2189-7824
Print ISSN : 0916-8443
ISSN-L : 2189-7824
特集 神経治療学の最前線 知っておきたい最近の開発動向,規制,研究基盤のトピック
医薬品等の開発に関わる国内規制にはどのようなものがあるか
橋詰 淳
著者情報
ジャーナル フリー

2025 年 42 巻 1 号 p. 13-18

詳細
抄録

Most medical research is mainly clinical research conducted to gain knowledge that contributes to promoting the public's health, patients' recovery from diseases, or improving the quality of life through understanding the causes of diseases. The establishment of full–fledged ethical guidelines for clinical research was concentrated after 2000. However, the ethical guidelines are not legally binding, nor is administrative guidance for failing to comply. Under such circumstances, the need for a legal system was considered, and the “Clinical Trials Act” was enacted and issued after thorough consideration of the scope of the legal regulations and the content of specific regulations and measures, and came into effect in April 2018.

With the enactment of the Clinical Trials Act, clinical research in Japan now includes clinical trials conducted under the “Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices”, clinical trials conducted under the “Clinical Trials Act”, and other clinical researches conducted under the “Ethical Guidelines for Medical and Health Research Involving Human Subjects”. In this manuscript, after mentioning the Declaration of Helsinki, on which these laws and regulations are based, the laws and regulations that must be complied with in the above three types of clinical research are summarized.

著者関連情報
© 2025 日本神経治療学会
前の記事 次の記事
feedback
Top